157 related articles for article (PubMed ID: 38015484)
41. Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas.
Sarris AH; Daliani D; Ulmer R; Crow M; Broxmeyer HE; Reiss M; Karasavvas N; Zelenetz AD; Pugh W; Cabanillas F; Deisseroth AB; Duvic M
Clin Cancer Res; 1997 Feb; 3(2):169-77. PubMed ID: 9815669
[TBL] [Abstract][Full Text] [Related]
42. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma.
Su IJ; Tsai TF; Cheng AL; Chen CC
J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):685-92. PubMed ID: 8227539
[TBL] [Abstract][Full Text] [Related]
43. Disparities in Cutaneous T-Cell Lymphoma Incidence by Race/Ethnicity and Area-Based Socioeconomic Status.
Wiese D; Stroup AM; Shevchenko A; Hsu S; Henry KA
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834276
[TBL] [Abstract][Full Text] [Related]
44. Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series.
Seçkin D; Barete S; Euvrard S; Francès C; Kanitakis J; Geusau A; Del Marmol V; Harwood CA; Proby CM; Ali I; Güleç AT; Durukan E; Lebbé C; Alaibac M; Laffitte E; Cooper S; Bouwes Bavinck JN; Murphy GM; Ferrándiz C; Mørk C; Cetkovská P; Kempf W; Hofbauer GF
Am J Transplant; 2013 Aug; 13(8):2146-53. PubMed ID: 23718915
[TBL] [Abstract][Full Text] [Related]
45. Cutaneous lymphomas and COVID-19: What is known so far?
Elmasry MF; Youssef R; Elbendary A; Helmy K; Abdelkader HA
Dermatol Ther; 2021 Jan; 34(1):e14463. PubMed ID: 33112053
[TBL] [Abstract][Full Text] [Related]
46. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
[TBL] [Abstract][Full Text] [Related]
47. Association of airborne toxins with geographic clustering of cutaneous T-cell lymphoma in Louisiana.
Maghfour J; Gill F; Olson J; Guido N; Echuri H; Murina A
J Am Acad Dermatol; 2022 Nov; 87(5):1184-1186. PubMed ID: 35271939
[No Abstract] [Full Text] [Related]
48. Characterization of primary cutaneous T-cell lymphoma following solid organ transplantation.
Shimshak S; Dai C; Comfere N; Sokumbi O
Int J Dermatol; 2023 Apr; 62(4):494-500. PubMed ID: 35687656
[TBL] [Abstract][Full Text] [Related]
49. Early detection of cutaneous lymphoma.
Abd-el-Baki J; Stefanato CM; Koh HK; Demierre MF; Foss FM
Oncology (Williston Park); 1998 Oct; 12(10):1521-30; discussion 1532-4. PubMed ID: 9798206
[TBL] [Abstract][Full Text] [Related]
50. Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas.
Sarris AH; Daliani D; Ulmer R; Crow M; Broxmeyer HE; Pugh W; Reiss M; Cabanillas F; Deisseroth AB; Duvic M
Leuk Lymphoma; 1996 Dec; 24(1-2):103-10. PubMed ID: 9049966
[TBL] [Abstract][Full Text] [Related]
51. Cutaneous T-cell lymphoma in Saudi Arabia: retrospective single-center review.
Binamer Y
Ann Saudi Med; 2017; 37(3):212-215. PubMed ID: 28578360
[TBL] [Abstract][Full Text] [Related]
52. Novel therapeutic approaches for cutaneous T cell lymphomas.
Pavlidis A; Piperi C; Papadavid E
Expert Rev Clin Immunol; 2021 Jun; 17(6):629-641. PubMed ID: 33890833
[No Abstract] [Full Text] [Related]
53. Primary Cutaneous Lymphomas in Thailand: A 10-Year Retrospective Study.
Pruksaeakanan C; Teyateeti P; Patthamalai P; Thumrongtharadol J; Chairatchaneeboon M
Biomed Res Int; 2021; 2021():4057661. PubMed ID: 34235215
[TBL] [Abstract][Full Text] [Related]
54. New insights into the applicability of T-cell receptor gamma gene rearrangement analysis in cutaneous T-cell lymphoma.
Li N; Bhawan J
J Cutan Pathol; 2001 Sep; 28(8):412-8. PubMed ID: 11493379
[TBL] [Abstract][Full Text] [Related]
55. Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma.
Rea B; Haun P; Emerson R; Vignali M; Farooqi M; Samimi S; Elenitsas R; Kirsch I; Bagg A
J Clin Pathol; 2018 Sep; 71(9):814-820. PubMed ID: 29636372
[TBL] [Abstract][Full Text] [Related]
56. Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma.
Schlaak M; Pickenhain J; Theurich S; Skoetz N; von Bergwelt-Baildon M; Kurschat P
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD008908. PubMed ID: 23986525
[TBL] [Abstract][Full Text] [Related]
57. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
Olsen EA
Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
[TBL] [Abstract][Full Text] [Related]
58. Pruritus in cutaneous T-cell lymphoma: a review.
Ahern K; Gilmore ES; Poligone B
J Am Acad Dermatol; 2012 Oct; 67(4):760-8. PubMed ID: 22285672
[TBL] [Abstract][Full Text] [Related]
59. Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Roshdy O; Pehr K; Sasseville D; Litvinov IV
J Cutan Med Surg; 2018; 22(2):154-165. PubMed ID: 29241349
[TBL] [Abstract][Full Text] [Related]
60. Hemophagocytic Lymphohistiocytosis in Cutaneous T-Cell Lymphoma.
Lee DE; Martinez-Escala ME; Serrano LM; Zhou XA; Kaplan JB; Pro B; Choi J; Guitart J
JAMA Dermatol; 2018 Jul; 154(7):828-831. PubMed ID: 29874360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
